Clinical Validation of a Size-Based Microfluidic Device for Circulating Tumor Cell Isolation and Analysis in Renal Cell Carcinoma

Clinical Validation of a Size-Based Microfluidic Device for Circulating Tumor Cell Isolation and Analysis in Renal Cell Carcinoma

Renal cell carcinoma (RCC) presents as metastatic disease in one third of cases. Research on circulating tumor cells (CTCs) and liquid biopsies is improving the understanding of RCC biology and metastases formation. However, a standardized, sensitive, specific, and cost-effective CTC detection techn...

Full description

Bibliographic Details
Main Authors: Tito Palmela Leitão, Patrícia Corredeira, Sandra Kucharczak, Margarida Rodrigues, Paulina Piairo, Carolina Rodrigues, Patrícia Alves, Ana Martins Cavaco, Miguel Miranda, Marília Antunes, João Ferreira, José Palma Reis, Tomé Lopes, Lorena Diéguez, Luís Costa
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:International Journal of Molecular Sciences
Subjects:
circulating tumor cell
kidney cancer
liquid biopsy
microfluidic
renal cell carcinoma
Online Access:https://www.mdpi.com/1422-0067/24/9/8404

Internet

https://www.mdpi.com/1422-0067/24/9/8404

Similar Items